NASDAQ · Financial Statements

ImageneBio, Inc. (IMA) Financial Statements

$4.00 NASDAQ: IMA Market Cap $45.41M

ImageneBio, Inc. most recently reported annual revenue of $1.0M, a net loss of $45.0M. Revenue declined at an average annual rate of 35.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$31.0M$16.0M$9.0M$4.0M$1.0M
Operating Profit$-34.0M$-71.0M$-75.0M$-37.0M$-48.0M
Net Profit$-34.0M$-69.0M$-68.0M$-37.0M$-45.0M
EPS$-11.38$-22.80$-19.60$-40.52$-9.64
Op Margin-110.2%-454.0%-823.3%-1057.1%-6056.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$248.0M$172.0M$192.0M$142.0M$153.0M
Total Liabilities$40.0M$25.0M$22.0M$16.0M$20.0M
Cash$232.0M$60.0M$120.0M$39.0M$35.0M
Borrowings$7.0M$6.0M$11.0M$8.0M$10.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-60.0M$-74.0M$-80.0M$-46.0M$-48.0M
Investing Cash Flow$-4.0M$-101.0M$64.0M$-35.0M$-6.0M
Financing Cash Flow$1.0M$1.0M$38.0M$0$55.0M
Net Cash Flow$70.0M$-172.0M$60.0M$-81.0M$82.0M
Free Cash Flow$-62.0M$-76.0M$-80.0M$-46.0M$-48.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA0.78
FCF Yield-112.50%
Quick Ratio21.47
Interest Coverage-614.18
Return 1Y-63.38%
Return 3Y-91.79%
Return 5Y-95.68%

ImageneBio, Inc. (IMA) financials — frequently asked questions

What is ImageneBio, Inc.'s annual revenue?

ImageneBio, Inc. (IMA) reported annual revenue of $1.0M in its most recent fiscal year.

What is ImageneBio, Inc.'s net profit?

ImageneBio, Inc. (IMA) reported a net loss of $45.0M in its most recent fiscal year.

What is IMA EV/EBITDA?

ImageneBio, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.78.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
IMA Overview IMA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.